Thomaz Alexandre Costa

10PUBLICATIONS
29CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Major global burdens of diseaseHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 20, 2025
Efficacy and safety of direct oral anticoagulants versus warfarin in patients with a left ventricular thrombus: an updated systematic review and meta-analysis of randomised controlled trials.

Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, Luma Maria Tavares de Sousa

|Jun 11, 2025
Incretin-based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials.

Thomaz Alexandre Costa, Nicole Felix, Gabriel Cavalcante Lima Chagas

|Dec 16, 2024
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: A Meta-analysis of Randomized Placebo-Controlled Trials.

Nicole Felix, Larissa Teixeira, Alleh Nogueira

|Jul 10, 2024
'X' marks the spot! Utilising factor Xa inhibitors to optimise thromboprophylaxis in multiple myeloma.

Thomaz Alexandre Costa, Nicole Felix, Joshua Richter

|Apr 12, 2024
Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis.

Bruno Almeida Costa, Thomaz Alexandre Costa, Kevin Pak

|Mar 15, 2024
Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis.

Bruno Almeida Costa, Thomaz Alexandre Costa, Sara Diaz Saravia

Pageof 2

Frequent Collaborators

6 joint publications

Nicole Felix

4 joint publications

Bruno Almeida Costa

3 joint publications

Joshua Richter

2 joint publications

Amanda Godoi